Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference22 articles.
1. Disparities in uptake of 13-valent pneumococcal conjugate vaccine among older adults in the United States;McLaughlin;Hum Vaccin Immunother,2019
2. Role of social determinants of health in pneumococcal vaccination among high-risk adults;Gatwood;Vaccine,2021
3. Pneumococcal disease;Gierke
4. Pneumococcal disease prevention among adults: strategies for the use of pneumococcal vaccines;Pilishvili;Am J Prev Med,2015
5. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP);Tomczyk;MMWR Morb Mortal Wkly Rep,2014